Nexalis Therapeutics LimitedASX: NX1

Study Order Executed for Phase 2 BTcP Trial

Mar 13, 2025 at 8:11 AM UTC · Issued by Nexalis Therapeutics Limited

Nexalis Therapeutics Limited has released a press release.

View Attachment